Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Microscopy Method Enables Detailed Whole Brain 3D RNA Analysis

By LabMedica International staff writers
Posted on 26 Nov 2024
Print article
Image: Image: Eight-week-old mouse brain (Photo courtesy of Science)
Image: Image: Eight-week-old mouse brain (Photo courtesy of Science)

Despite significant advancements in RNA analysis, linking RNA data to its spatial context, particularly in intact, detailed three-dimensional (3D) tissue volumes, has remained a challenging task. Researchers have now developed a microscopy technique that allows for detailed 3D RNA analysis at the cellular level within whole, intact mouse brains. This new method, known as TRISCO, has the potential to revolutionize our understanding of brain function in both healthy and diseased states, as demonstrated in a study published in Science.

The TRISCO technique, developed by researchers at Karolinska Institutet (Stockholm, Sweden) and Karolinska University Hospital (Stockholm, Sweden), enables 3D RNA imaging of entire mouse brains without requiring the brain to be sliced into thin sections, which was a necessary step in previous methods. In the study, up to three different RNA molecules were analyzed simultaneously. The researchers plan to expand this technique to analyze approximately one hundred RNA molecules using multiplex RNA analysis, which could provide even deeper insights into brain function and disease mechanisms.

The TRISCO method opens up new avenues for studying the intricate complexity of the brain, potentially leading to the development of novel treatments for a variety of brain disorders. While the study focused on intact mouse brains, it also shows that the TRISCO method is adaptable to larger brains, such as those of guinea pigs, as well as various tissues, including the kidney, heart, and lungs.

“This method is a powerful tool that can drive brain research forward. With TRISCO, we can study the complex anatomical structure of the brain in a way that was previously not possible,” said Per Uhlén, professor at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet, and the study's last author.

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
Amoebiasis Test
ELI.H.A Amoeba

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.